Compounds > lactic acid

lactic acid and levetiracetam

lactic acid has been researched along with levetiracetam in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Balestri, M; Bianchi, R; Cilio, MR; Di Capua, M; Giovannini, S; Onofri, A; Vigevano, F1
Campbell, TE; Cook, MJ; Halliday, AJ; McLean, KJ; Nelson, TS; Razal, JM; Wallace, GG1
Campbell, TE; Cook, MJ; Halliday, AJ; McLean, KJ; Nelson, TS; Wallace, GG1
Gureviciene, I; Jin, N; Tanila, H; Ziyatdinova, S1

Other Studies

6 other study(ies) available for lactic acid and levetiracetam

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Intravenous levetiracetam terminates refractory status epilepticus in two patients with migrating partial seizures in infancy.
    Epilepsy research, 2009, Volume: 86, Issue:1

    Topics: Ammonia; Anticonvulsants; Blood Cell Count; Creatine; Drug Administration Schedule; Electroencephalography; Epilepsy, Partial, Sensory; Follow-Up Studies; Humans; Infant; Infusions, Intravenous; Lactic Acid; Levetiracetam; Liver; Male; Piracetam; Status Epilepticus

2009
In vivo biocompatibility and in vitro characterization of poly-lactide-co-glycolide structures containing levetiracetam, for the treatment of epilepsy.
    Journal of biomedical materials research. Part A, 2012, Volume: 100, Issue:2

    Topics: Animals; Anticonvulsants; Brain; Epilepsy; Glial Fibrillary Acidic Protein; Lactic Acid; Levetiracetam; Male; Materials Testing; Microscopy, Electron, Scanning; Piracetam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats, Sprague-Dawley; Time Factors

2012
Levetiracetam-loaded biodegradable polymer implants in the tetanus toxin model of temporal lobe epilepsy in rats.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2013, Volume: 20, Issue:1

    Topics: Absorbable Implants; Animals; Anticonvulsants; Disease Models, Animal; Drug Delivery Systems; Electroencephalography; Epilepsy, Temporal Lobe; Lactic Acid; Levetiracetam; Male; Neurotoxins; Piracetam; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Sprague-Dawley; Tetanus Toxin; Time Factors

2013
Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs.
    Scientific reports, 2020, 07-16, Volume: 10, Issue:1

    Topics: 3-Hydroxybutyric Acid; Action Potentials; Alzheimer Disease; Animals; Anticonvulsants; Atropine; Disease Models, Animal; Donepezil; Drug Administration Schedule; Electroencephalography; Epilepsy; Ethosuximide; GABA Antagonists; Humans; Injections, Intraperitoneal; Lactic Acid; Levetiracetam; Male; Mice; Mice, Transgenic; Nootropic Agents; Organophosphorus Compounds; Parasympatholytics; Plaque, Amyloid; Pyruvic Acid; Video Recording

2020